Monograph
Cabergoline: A Practical Guide
Overview Cabergoline (Dostinex®) is a long-acting, highly selective dopamine D2 and D3 receptor agonist derived from ergot alkaloids. It is FDA-approved for treatment of hyperprolactinemia — excess prolactin production, which suppresses the hypothalamic-pituitary-gonadal (HPG) axis, causing…
By Kristopher Crawford
·
13 May 2026
·
5 min read
Overview Cabergoline (Dostinex®) is a long-acting, highly selective dopamine D2 and D3 receptor agonist derived from ergot alkaloids. It is FDA-approved for treatment of hyperprolactinemia — excess prolactin production, which suppresses the hypothalamic-pituitary-gonadal (HPG) axis, causing…
In the full monograph
- What it is, and how it works
- What the evidence shows — randomized trials, observational data, animal studies, graded and cited
- Dose, form, and timing
- What to expect, and how soon
- Who should be careful, and what to check first
- The verdict
MEMBERS
Read the full monograph
Members get every monograph in the library, the research assistant, and the stack tracker — with a 30-day money-back guarantee. Not ready? Start free with the Proven Supplements Starter Guide.